Polypharmacology by Design: A Medicinal Chemist’s Perspective on Multitargeting Compounds
Ewgenij Proschak(Goethe University Frankfurt), Daniel Merk(Goethe University Frankfurt), Holger Stark(Heinrich Heine University Düsseldorf)
Cited by 476
Related Papers
International Union of Basic and Clinical Pharmacology. XCVIII. Histamine Receptors
|Pharmacological Reviews|2015|558
Attenuation of levodopa-induced dyskinesia by normalizing dopamine D3 receptor function
|Nature Medicine|2003|381
DOGS: Reaction-Driven de novo Design of Bioactive Compounds
|PLoS Computational Biology|2012|264
Neurochemical and Behavioral Effects of Ciproxifan, A Potent Histamine H3-Receptor Antagonist
|Journal of Pharmacology and Experimental Therapeutics|1998|240
BF2.649 [1-{3-[3-(4-Chlorophenyl)propoxy]propyl}piperidine, Hydrochloride], a Nonimidazole Inverse Agonist/Antagonist at the Human Histamine H3 Receptor: Preclinical Pharmacology
|Journal of Pharmacology and Experimental Therapeutics|2006|234